GENB · Expected Move
Generate Biomedicines, Inc. Common Stock
The expected move for GENB is derived from at-the-money straddle pricing — the market's implied one-standard-deviation move through the next 30 days. Comparing it to realized moves reveals when options are pricing in too much (premium-selling regime) vs too little (premium-buying regime).
GENB straddle price & implied vol
13 sessionsBars: at-the-money straddle price (30-day and 7-day) — the market's priced move. Line: 30-day at-the-money implied volatility (right axis).
Current GENB Expected Move
30-Day Straddle
$3.85
7-Day Straddle
$3.85
30-Day ATM IV
77.3%
IV Rank
—
Implied one-standard-deviation move through the next 30 days. Compare to GENB's realized
move over the same window to gauge whether options are pricing in too much (premium-selling regime)
or too little (premium-buying regime). The
Expected Move Tracker ranks every symbol by
this measure.
GENB Straddle Price — Last 60 Days
| Date | 30D Straddle | 7D Straddle | ATM IV | IV Rank |
|---|---|---|---|---|
| 20261026 | $3.85 | $3.85 | 77.3% | — |
| 20261023 | $2.23 | $2.23 | 80.6% | — |
| 20261022 | $2.33 | $2.33 | 84.0% | — |
| 20261021 | $2.38 | $2.38 | 78.9% | — |
| 20261020 | $2.33 | $2.33 | 77.1% | — |
| 20261019 | $3.75 | $3.75 | 103.3% | — |
| 20261016 | $2.48 | $0.60 | 81.1% | — |
| 20261015 | $2.62 | $0.78 | 79.4% | — |
| 20261014 | $2.67 | $0.72 | 84.8% | — |
| 20261013 | $2.03 | $0.82 | 66.2% | — |
| 20261012 | $3.18 | $2.88 | 85.5% | — |
| 20261009 | $3.33 | $1.30 | 83.0% | — |
| 20261008 | $3.42 | $1.57 | 88.5% | — |
More on GENB
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.